Skip to main content
VIVOZON PHARMACEUTICAL CO., LTD. logo

VIVOZON PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 082800 ISIN · KR7082800004 KO Manufacturing
Open in API
Filings indexed 590 across all filing types
Latest filing 2025-07-14 Report Publication Anno…
Country KR South Korea
Listing KO 082800

About VIVOZON PHARMACEUTICAL CO., LTD.

https://www.vivozon.com/

VIVOZON PHARMACEUTICAL CO., LTD. is a research and development company specializing in the discovery and commercialization of innovative drugs, with a primary focus on pain and central nervous system (CNS) diseases. The company utilizes a multi-target drug development platform to create new chemical entities that act on multiple targets to achieve synergistic efficacy. This approach integrates efficacy-based screening from the early stages of discovery to identify candidate substances with a high potential for successful clinical development. Its lead pipeline candidate is Opiranserin (VVZ-149), a first-in-class, non-narcotic injectable analgesic for post-operative pain management. The company is actively expanding its pipeline to address a broader range of unmet medical needs within the CNS field.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling of an Investor Relations (IR) meeting. It provides details such as the date, time, location, target audience, and purpose of the meeting. Since it is an announcement of an upcoming event rather than the presentation materials themselves, and it does not fit into other specific categories like 'Investor Presentation' (IP), it is classified as a Regulatory Filing (RNS) as it serves as a standard corporate disclosure announcement.
2025-07-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (Vivozon Holdings) and special related parties (Lee Doo-hyun), including share acquisitions and collateral agreements. This corresponds to the 'Major Shareholding Notification' category.
2025-06-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details the share transactions (insider trading) of a director (Lee Doohyun) of Vivozon Pharmaceutical. This falls under the category of Director's Dealing (DIRS).
2025-06-16 Korean
임원ㆍ주요주주특정증권등거래계획보고서
Major Shareholding Notification Classification · 100% confidence The document is an '임원ㆍ주요주주 특정증권등 거래계획보고서' (Report on Trading Plan for Specific Securities by Executives and Major Shareholders). This is a regulatory filing required by the Financial Services Commission and the Korea Exchange in South Korea when major shareholders or executives plan to trade company securities. It details the reporting entity (Vivozon Holdings), the issuer (Vivozon Pharmaceutical), the trading plan, and the ownership status. This falls under the category of regulatory filings for insider trading plans.
2025-05-22 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Vivozon Pharmaceutical' (주식회사 비보존제약) covering the period from January 1, 2025, to March 31, 2025. It contains detailed financial information, business overviews, capital structure, and management details, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (Vivozon Holdings) and its special related parties in the company 'Vivozon Pharmaceutical'. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-04-18 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.